MENAWAT ARUN SWARUP (CEO) purchased 3.9% of their position (22.03K shares) of PROFOUND MEDICAL CORP. on the open market
Open‑market purchase worth $100.2K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/20/2025ACC: 0001171843-25-003336
DirectorOfficer· CEO
Since May 2025
+22.03K
Net shares
Net buyer
$100.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
22.03K acquired
Non-Derivative Transactions2
Common Shares
Direct
Shares
+10K
Price / share
$4.33
Trade value
$43.26K
% of position
1.8%
5/15/2025
565.06K→575.06K
Common Shares
Direct
Shares
+12.03K
Price / share
$4.73
Trade value
$56.89K
% of position
2.1%
5/16/2025
575.06K→587.09K
Total
Net shares
+22.03K
Net value
$100.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 5/15/2025 | P · Purchase | +10K | $4.33 | $43.26K | 1.8% | 565.06K | 575.06K |
| Common Shares Direct | 5/16/2025 | P · Purchase | +12.03K | $4.73 | $56.89K | 2.1% | 575.06K | 587.09K |
| Total | +22.03K | $100.15K | ||||||
Derivative Transactions0
No derivative transactions reported